Events & Presentations
Board of Directors
Historic Stock Lookup
Galectin Therapeutics Issues Statement Regarding GALTW and GALTU
March 23, 2017 | Press Release
Galectin Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update
March 21, 2017 | Press Release
GR-MD-02 Demonstrates Clinically Significant Effect in Patients with Severe and Refractory Atopic Dermatitis (Eczema)
March 14, 2017 | Press Release
Why did you choose to become the CEO of Galectin Therapeutics?
Are you conducting clinical trials with GR-MD-02? What results have you seen so far?
Can you give me a quick overview of Galectin Therapeutics and the opportunity it sees for GR-MD-02?
Why are the results of the GR-MD-02 psoriasis study so promising?
Why is the NASH-CX trial so important?
See all videos
Galectin Therapeutics, Inc.
Financial Tear Sheet
Filings & Reports
Stock price updates every 30 minutes.
Latest Corporate Presentation
Media Fact Sheet
Corporate Fact Sheet
© 2017 Galectin Therapeutics Inc. - All Rights Reserved
Disclaimer: This site may contain